Role of estrogen deficiency in pathogenesis of secondary hyperparathyroidism and increased bone resorption in elderly women

W. R. McKane, Sundeep Khosla, J. Risteli, S. P. Robins, J. M. Muhs, B. L. Riggs

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Whether the increased bone resorption and secondary hyperparathyroidism in elderly women is due to aging or to estrogen deficiency is unclear. To address this issue, we measured serum intact parathyroid hormone (PTH) and biochemical markers in serum and urine samples from 30 premenopausal women (32 ± 0.5 years, mean age ± SE), 30 estrogen-deficient postmenopausal women (74.2 ± 0.6 years), and 30 elderly women (73.8 ± 0.6 years) receiving long- term estrogen treatment. Because the first and third groups were comparable in estrogen status but not in age, whereas the second and third groups were comparable in age but not in estrogen status, the independent effects of age and estrogen deficiency could be assessed quantitatively. Mean values were higher in the estrogen-deficient postmenopausal women than in the premenopausal women for serum PTH (by 33%, p < .01) and for bone resurption markers [by 50% (p < .001) for urine cross-linked N-teleopeptide of type 1 collagen (NTx); 34% (p < .001) for urine pyridinoline (Pyd); and 36% (p < .001) for urine deoxypyridinoline (Dpd)]. However, mean values for serum PTH in the postmenopausal women receiving estrogen treatment did not differ from those in the premenopausal women, and mean values for bone resorption markers were not different (urine NTx and Pyd) or were lower [urine Dpd, by -12%, (p < .005)]. These findings suggest that late consequences of estrogen deficiency rather than age-related processes per se are the principal causes of the secondary hyperparathyroidism and increased bone resorption in elderly women.

Original languageEnglish (US)
Pages (from-to)174-180
Number of pages7
JournalProceedings of the Association of American Physicians
Volume109
Issue number2
StatePublished - 1997

Fingerprint

Secondary Hyperparathyroidism
Bone Resorption
Estrogens
Urine
Parathyroid Hormone
Serum
Silicone Elastomers
Collagen Type I
Biomarkers
Bone and Bones

Keywords

  • aging
  • bone formation
  • collagen degradation
  • collagen synthesis
  • estrogen therapy
  • osteoporosis
  • serum PTH

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Role of estrogen deficiency in pathogenesis of secondary hyperparathyroidism and increased bone resorption in elderly women. / McKane, W. R.; Khosla, Sundeep; Risteli, J.; Robins, S. P.; Muhs, J. M.; Riggs, B. L.

In: Proceedings of the Association of American Physicians, Vol. 109, No. 2, 1997, p. 174-180.

Research output: Contribution to journalArticle

@article{7884652777b14086a3c588c1367cb6c8,
title = "Role of estrogen deficiency in pathogenesis of secondary hyperparathyroidism and increased bone resorption in elderly women",
abstract = "Whether the increased bone resorption and secondary hyperparathyroidism in elderly women is due to aging or to estrogen deficiency is unclear. To address this issue, we measured serum intact parathyroid hormone (PTH) and biochemical markers in serum and urine samples from 30 premenopausal women (32 ± 0.5 years, mean age ± SE), 30 estrogen-deficient postmenopausal women (74.2 ± 0.6 years), and 30 elderly women (73.8 ± 0.6 years) receiving long- term estrogen treatment. Because the first and third groups were comparable in estrogen status but not in age, whereas the second and third groups were comparable in age but not in estrogen status, the independent effects of age and estrogen deficiency could be assessed quantitatively. Mean values were higher in the estrogen-deficient postmenopausal women than in the premenopausal women for serum PTH (by 33{\%}, p < .01) and for bone resurption markers [by 50{\%} (p < .001) for urine cross-linked N-teleopeptide of type 1 collagen (NTx); 34{\%} (p < .001) for urine pyridinoline (Pyd); and 36{\%} (p < .001) for urine deoxypyridinoline (Dpd)]. However, mean values for serum PTH in the postmenopausal women receiving estrogen treatment did not differ from those in the premenopausal women, and mean values for bone resorption markers were not different (urine NTx and Pyd) or were lower [urine Dpd, by -12{\%}, (p < .005)]. These findings suggest that late consequences of estrogen deficiency rather than age-related processes per se are the principal causes of the secondary hyperparathyroidism and increased bone resorption in elderly women.",
keywords = "aging, bone formation, collagen degradation, collagen synthesis, estrogen therapy, osteoporosis, serum PTH",
author = "McKane, {W. R.} and Sundeep Khosla and J. Risteli and Robins, {S. P.} and Muhs, {J. M.} and Riggs, {B. L.}",
year = "1997",
language = "English (US)",
volume = "109",
pages = "174--180",
journal = "Proceedings of the Association of American Physicians",
issn = "1081-650X",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Role of estrogen deficiency in pathogenesis of secondary hyperparathyroidism and increased bone resorption in elderly women

AU - McKane, W. R.

AU - Khosla, Sundeep

AU - Risteli, J.

AU - Robins, S. P.

AU - Muhs, J. M.

AU - Riggs, B. L.

PY - 1997

Y1 - 1997

N2 - Whether the increased bone resorption and secondary hyperparathyroidism in elderly women is due to aging or to estrogen deficiency is unclear. To address this issue, we measured serum intact parathyroid hormone (PTH) and biochemical markers in serum and urine samples from 30 premenopausal women (32 ± 0.5 years, mean age ± SE), 30 estrogen-deficient postmenopausal women (74.2 ± 0.6 years), and 30 elderly women (73.8 ± 0.6 years) receiving long- term estrogen treatment. Because the first and third groups were comparable in estrogen status but not in age, whereas the second and third groups were comparable in age but not in estrogen status, the independent effects of age and estrogen deficiency could be assessed quantitatively. Mean values were higher in the estrogen-deficient postmenopausal women than in the premenopausal women for serum PTH (by 33%, p < .01) and for bone resurption markers [by 50% (p < .001) for urine cross-linked N-teleopeptide of type 1 collagen (NTx); 34% (p < .001) for urine pyridinoline (Pyd); and 36% (p < .001) for urine deoxypyridinoline (Dpd)]. However, mean values for serum PTH in the postmenopausal women receiving estrogen treatment did not differ from those in the premenopausal women, and mean values for bone resorption markers were not different (urine NTx and Pyd) or were lower [urine Dpd, by -12%, (p < .005)]. These findings suggest that late consequences of estrogen deficiency rather than age-related processes per se are the principal causes of the secondary hyperparathyroidism and increased bone resorption in elderly women.

AB - Whether the increased bone resorption and secondary hyperparathyroidism in elderly women is due to aging or to estrogen deficiency is unclear. To address this issue, we measured serum intact parathyroid hormone (PTH) and biochemical markers in serum and urine samples from 30 premenopausal women (32 ± 0.5 years, mean age ± SE), 30 estrogen-deficient postmenopausal women (74.2 ± 0.6 years), and 30 elderly women (73.8 ± 0.6 years) receiving long- term estrogen treatment. Because the first and third groups were comparable in estrogen status but not in age, whereas the second and third groups were comparable in age but not in estrogen status, the independent effects of age and estrogen deficiency could be assessed quantitatively. Mean values were higher in the estrogen-deficient postmenopausal women than in the premenopausal women for serum PTH (by 33%, p < .01) and for bone resurption markers [by 50% (p < .001) for urine cross-linked N-teleopeptide of type 1 collagen (NTx); 34% (p < .001) for urine pyridinoline (Pyd); and 36% (p < .001) for urine deoxypyridinoline (Dpd)]. However, mean values for serum PTH in the postmenopausal women receiving estrogen treatment did not differ from those in the premenopausal women, and mean values for bone resorption markers were not different (urine NTx and Pyd) or were lower [urine Dpd, by -12%, (p < .005)]. These findings suggest that late consequences of estrogen deficiency rather than age-related processes per se are the principal causes of the secondary hyperparathyroidism and increased bone resorption in elderly women.

KW - aging

KW - bone formation

KW - collagen degradation

KW - collagen synthesis

KW - estrogen therapy

KW - osteoporosis

KW - serum PTH

UR - http://www.scopus.com/inward/record.url?scp=0030981875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030981875&partnerID=8YFLogxK

M3 - Article

C2 - 9069586

AN - SCOPUS:0030981875

VL - 109

SP - 174

EP - 180

JO - Proceedings of the Association of American Physicians

JF - Proceedings of the Association of American Physicians

SN - 1081-650X

IS - 2

ER -